Physician profile
Emma E Cummins
NPI 1043881907
$774.76
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.17 · 2022: $149 · 2023: $71.27 · 2024: $361 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $182.56 | 2023-2024 | Myrisk |
| W. L. Gore & Associates, INC. | $163.20 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $138.95 | 2024-2025 | Keytruda, Lynparza |
| Tela Bio, INC. | $79.16 | 2024 | Ovitex 2s |
| Medtronic, INC. | $50.00 | 2025 | Valleylab Ft10 |
| Tactile Systems Technology INC | $48.47 | 2025 | Nimbl, Flexitouch Plus |
| Boston Scientific Corporation | $30.85 | 2023 | Wavewriter Alpha Prime 16 |
| Blue Earth Diagnostics | $24.14 | 2024 | |
| Merit Medical Systems INC | $20.47 | 2025 | Savi Scout |
| Stryker Corporation | $18.83 | 2025 | Molli |
| Vertex Pharmaceuticals Incorporated | $18.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Cummins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.